SCHEMBL7987452

SCHEMBL7987452

CC(Nc1nccc(-n2cnc3cc(-c4ccncc4)ccc32)n1)C1CCCN(C(=O)Nc2ccccc2)C1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7510219 0.93 LCK (0.77) LCK
SCHEMBL7569953 0.90 LCK (0.81) LCK
SCHEMBL7556006 0.89 LCK (0.83) LCK
SCHEMBL7588289 0.89 LCK (0.75) LCK
SCHEMBL7986827 0.89 LCK (0.75) LCK
SCHEMBL7591203 0.89 LCK (1.00) LCK
SCHEMBL7541451 0.89 LCK (0.81) LCK
SCHEMBL7586925 0.86 LCK (0.81) LCK
SCHEMBL7551010 0.85 LCK (0.75) LCK
SCHEMBL7593737 0.84 LCK (0.87) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329380-B1 PYRIMIDINE BENZIMIDIZAZOLE, PYRIMIDINEIMIDAZOLE OR PYRIDINE IMIDAZOLE COMPOUNDS FOR ANTICANCER AGENTS OR ATHEROSCLEROSIS MERCK & CO., INC. 2001-12-11 US claimed
US-6329380-B1 PYRIMIDINE BENZIMIDIZAZOLE, PYRIMIDINEIMIDAZOLE OR PYRIDINE IMIDAZOLE COMPOUNDS FOR ANTICANCER AGENTS OR ATHEROSCLEROSIS MERCK & CO., INC. 2001-12-11 US disclosed